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Family and twin studies provide strong evidence that genetic factors are involved in the transmission of Gilles
de la Tourette syndrome (TS) and related psychiatric disorders. To detect the underlying susceptibility gene(s)
for TS, we performed linkage analysis in one large French Canadian family (127 members) from the Charlevoix
region, in which 20 family members were definitely affected by TS and 20 others showed related tic disorders.
Using model-based linkage analysis, we observed a LOD score of 3.24 on chromosome 11 (11q23). This result
was obtained in a multipoint approach involving marker D11S1377, the marker for which significant linkage
disequilibrium with TS recently has been detected in an Afrikaner population. Altogether, 25 markers were
studied, and, for level of significance, we derived a criterion that took into account the multiple testing arising
from the use of three phenotype definitions and three modes of inheritance, a procedure that yielded a LOD
score of 3.18. Hence, even after adjustment for multiple testing, the present study shows statistically significant
evidence for genetic linkage with TS.
Gilles de la Tourette syndrome (TS [MIM 137580])
is a neuropsychiatric disorder with onset during child-
hood and is characterized by chronic intermittent mo-
tor and vocal tics (The Tourette Syndrome Classifi-
cation Study Group 1993; American Psychiatric
Association 1994). Despite an undeniable demonstra-
tion of a genetic component in TS, linkage studies
have not yet been successful in determining the chro-
mosomal location of a susceptibility gene for TS (for
a review, see Barr and Sandor 1998). Recently, two
genome screens were completed. In the first one, in-
volving 386 markers (Barr et al. 1999), no LOD score
12 was found by a model-based linkage analysis, but
the model-free analysis yielded eight low P values that
the authors of the study interpreted with caution,
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given that the affected-pedigree method that they used
is known to have a high false-positive rate. The Tour-
ette Syndrome Association International Consortium
for Genetics (1999) also performed a genome screen,
which was based on 110 sib pairs. Although no results
reached acceptable statistical significance, suggestive
results were found in two regions (4q and 8p). The
lack of definite evidence for linkage with TS, as well
as the inconsistencies among linkage results obtained
so far, may be due to either obstructing factors, such
as the uncertainty regarding the mode of inheritance
for TS and the exact phenotype definition, or com-
plicating factors such, as locus heterogeneity.
Attempts to detect linkage disequilibrium between
various candidate genes, mainly dopamine-receptor
genes, and TS also have led to inconclusive results,
mainly because of an inability to replicate original
suggestive results (for a review, see Barr and Sandor
1998). However, more recently, a large-scale associ-
ation study in an Afrikaner population, which com-
pared DNA samples from patients affected by TS ver-
sus those of unaffected control subjects, yielded
promising results (Simonic et al. 1998). Of the 1,167
Figure 1 Large French Canadian family (127 members) from the Charlevoix region in the province of Que´bec, in which (i) 20 members
were affected by definitive TS; (ii) 33 members entered the intermediate phenotype definition, which includes definite TS, definite CMT, definitive
CST, and OCD; and (iii) 40 members were classified as belonging to the broad phenotype definition that added definite NST to the intermediate
definition. To preserve the anonymity of the family, 15 members have been omitted from the pedigree shown in the figure, the sex of some
individuals has been changed (although the family sex ratio remains the same), and a few deceased subjects are designated as being alive, and
vice versa. One particularity of this pedigree is the presence of two marriage loops: three individuals from one family (subjects 9, 11, and 13)
are married to three individuals belonging to another family (subjects 10, 12, and 57, respectively). For eachmember, haplotypes were constructed
on chromosome 11, by use of markers D11S1377 and D11S933. The two boxes enclosed by broken lines contain the two family branches that
did not contribute to the LOD-score result for chromosome 11.
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Table 1
Descriptive Data on 127 Family Members, by Phenotype
PHENOTYPE AND
AFFECTION STATUS (N)
PROPORTION
OF MALES
(%)
MEAN AGE  SD
(years)
At Onset
When
Studied
Narrow:
Affected (20) 55.0 7.1  2.1 30.7  17.3
Unknown (49) 46.9 … 41.4  21.8
Unaffected (58) 53.4 … 37.7  17.2
Intermediate:
Affected (33) 45.4 7.2  2.2 29.7  15.7
Unknown (36) 55.5 … 46.2  22.4
Unaffected (58) 53.4 … 37.7  17.2
Broad:
Affected (40) 47.5 7.9  3.8 34.3  20.9
Unknown (29) 51.7 … 43.9  20.3
Unaffected (58) 53.4 … 37.7  17.2
NOTE.—Of the 127 family members, 101 were genotyped.
markers tested, 24 reached a significance level that
suggested disequilibrium, according to a two-stage
strategy that incorporated a confirmatory sample. We
selected these 24 markers to investigate genetic link-
age with TS in the large Charlevoix family (fig. 1) that
we studied, in which 20 members were definitely af-
fected by TS and in which 20 others showed related
tic disorders. The 24 markers are listed in tables 2
and 3 of the article by Simonic et al. (1998) and cover
12 chromosomes (1, 2, 4–6, 8, 11–14, 20, and 21).
We added marker D13S1325 to this list, to obtain
two adjacent markers on chromosome 13. The Char-
levoix region, an area of 100 # 10-15 km that is
located in the eastern part of the province of Que´bec,
is a particularly suitable region for genetic studies,
because of its founder effect (Morissette 1991).
Family members were given a personal explanation
of the study and signed a consent form. All subjects
were evaluated at home, with the Schedule for Tour-
ette and Other Behavioral Syndromes (Pauls and
Hurst 1987). A review of the past and present medical
history was also done. All adults and children 19 years
of age were personally interviewed. For the children
!18 years of age, an interview concerning the child
was also conducted with one of the parents (usually
the mother). Every interview was audiotaped. The in-
terview lasted 1–3 h and was conducted by trained
psychiatric nurses. Family history (FH) interviews us-
ing the Family History Method Using Diagnostic Cri-
teria (Andreasen et al. 1977) and some sections of the
Family Informant Criteria (Pauls and Hurst 1987)
were conducted with close relatives, to collect data
about each subject. Medical records were obtained
with the written consent of the subject.
Consensus best-estimate diagnoses were made on the
basis of the aforementioned sources of information; for
each subject, a board of three of the four certified psy-
chiatrists (C.C., H.B., A.P., and F.R.), who were blinded
with regard to both the subject’s position within the
pedigree and the presence of any psychiatric disorder in
close family members, was formed. Two members of the
board reviewed the information independently of each
other. Then the board met to discuss and decide on a
diagnosis. The diagnostic criteria were based on those
developed for TS genetic-linkage studies and were from
either The Tourette Syndrome Classification Study
Group (1993), in the case of TS, and the fourth edition
of the Diagnostic and Statistical Manual of Mental Dis-
orders (American Psychiatric Association 1994), in the
case of all other psychiatric disorders. A diagnosis was
considered definite only if all diagnostic criteria were
met.
Of the 127 family members, 103 were interviewed
directly. Sixteen additional individuals were evaluated
on the basis of FH interviews. A mean of 3.0 FH inter-
views was conducted on each subject. Eight subjects re-
ceived a diagnosis of “unknown,” because of a lack of
information. Blood samples were collected from 101
family members, for immortalization of the cells and
DNA extraction. Forty subjects were classified as defi-
nitely affected: 20 subjects had definite TS, 4 had def-
inite chronic multiple motor- or phonic-tic disorder (re-
ferred to as “chronic multiple tics” [CMT]), 7 had a def-
inite chronic single-tic disorder (CST), 7 had definite
nonspecific-tic disorder (NST), and 2 had obsessive-
compulsive disorder (OCD) without one of the other
diagnoses.
Given the uncertainty regarding the exact phenotype
definition to be used in a genetic study of TS, we defined
three phenotypes: (1) a narrow definition, which in-
cluded definite TS only ( ); (2) an intermediateNp 20
definition, which included definite TS, definite CMT, def-
inite CST, and definite OCD ( ); and (3) a broadNp 33
definition, which added definite NST to the immediately
preceding definition ( ). Subjects having one ofNp 40
the diagnoses included in the definition in use were clas-
sified as “affected.” Subjects with either a nondefinite
diagnosis or a diagnosis included within the broad phe-
notype definition but not included within the definition
in use were classified as “unknown.” The 58 subjects
who did not show any symptom related to the diagnoses
included within the broad phenotype definition were
classified as “unaffected,” regardless of the phenotype
definition in use. Table 1 provides, for each phenotype
definition, the number of subjects per affection status,
the proportion of males, the mean age at onset, and the
mean age at the time of the study.
Manual radioactive genotyping was performed essen-
tially according to the method of Maziade et al. (1997),
by means of MapPairs primers purchased from Re-
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Table 2
Penetrance Parameter Values Used in the Present Linkage Study
SEX AND AGE
PENETRANCE FORa
Model 1 Model 2 Model 3
tt Tt TT tt Tt TT tt Tt TT
Males:
0–5 years 0 .126 .126 .0005 .196 .196 .0013 .126 .126
6–10 years 0 .219 .219 .0021 .425 .425 .0022 .219 .219
11–15 years 0 .311 .311 .0033 .654 .654 .0031 .311 .311
16–20 years 0 .404 .404 .0044 .884 .884 .0040 .404 .404
21 years 0 .450 .450 .0050 .999 .999 .0045 .450 .450
Females:
0–5 years 0 .048 .048 0 .098 .098 .0013 .126 .126
6–10 years 0 .083 .083 0 .233 .233 .0022 .219 .219
11–15 years 0 .118 .118 0 .367 .367 .0031 .311 .311
16–20 years 0 .153 .153 0 .502 .502 .0040 .404 .404
21 years 0 .170 .170 0 .569 .569 .0045 .450 .450
a Data are the probabilities of having TS, for each of the three possible genotypes—tt,
Tt, and TT (where the T allele identifies the susceptibility allele). Models 1 and 2 are
from Gelernter et al. (1990); model 3 was derived to better suit our data from the family
that we studied. The disease-gene frequency used for models 1, 2, and 3 was .0004,
.003, and .0004, respectively.
search Genetics. The information pertinent to the in-
formativity and the relative map positions of the geno-
typed microsatellite loci was extracted from either The
Genome Database, The Cooperative Human Linkage
Center, or the Center for Medical Genetics, Marshfield
Medical Research Foundation. Allele frequencies were
estimated on the basis of a sample of 168 unrelated
subjects that included the 16 spouses in the Charlevoix
family.
Although the mode of inheritance for TS is uncer-
tain (Seuchter et al. 2000), model-based (or parametric)
linkage analyses (Ott 1991 ) were performed, since there
is growing evidence that, even when the mode of inher-
itance specified is only approximately correct, this
method is more powerful than model-free (or nonpara-
metric) analysis (Durner et al. 1999). Two-point LOD
scores were computed by the FASTLINK version (Scha¨f-
fer 1996) of the LINKAGE programs (Lathrop et al.
1984). When a two-point LOD score was 11.0, a three-
point analysis was performed with both the marker in-
volved in the two-point result and the most adjacent
marker.
We used the two autosomal dominant inheritance
models proposed by Gelernter et al. (1990). Table 2
shows the corresponding age-dependent penetrances.
In both models, the penetrance was higher in males
than in females, but model 2 assumed an almost com-
pletely penetrant gene and some phenocopy for males.
Given that, in this family, males and females were
equally likely to be affected, we derived a third model
(model 3 in table 2), which better suited our data, via
a few modifications of model 1: model 3 assumed
reduced penetrances and no dependence on gender
and allowed for phenocopy. Model 1 was used for
the analysis with the narrow phenotype definition,
whereas model 2 was used for the analysis with the
intermediate and broad phenotype definitions. Model
3 was used with each of the three phenotype defini-
tions. Hence, each marker was analyzed six times. For
each marker, the best result was, then, a mod score
obtained by maximization of the maximum LOD
score (Zmax; maximized over the recombination frac-
tion [v]) for these six combinations. Although this
mod-score approach has a greater power to detect
linkage than does a single model (Hodge and Elston
1994), the major drawback is an inevitable inflation
of the rate of type I error. To correct for such multiple
testing, we raised the Z criterion for level of signifi-
cance (Morton 1955) by .18, following the guidelines
of Hodge et al. (1997). Hence, in our study, the hy-
pothesis of no linkage was rejected if a mod score was
13.18. The LOD-score thresholds for significance that
have been proposed by Lander and Kruglyak (1995)
were not appropriate for the present study, because
we did not perform a whole-genome scan.
According to the two-point linkage analysis, two
markers yielded LOD scores 12. When model 3 and the
narrow phenotype definition were used, Z p 2.40max
( ) was obtained at D11S1377, whereasvp .10 Z pmax
( ) was obtained at D13S788. Table 3 shows3.2 vp .0
the two-point Zmax values obtained for chromosomes 11
and 13, for each of the six combinations of a phenotype
definition (table 1) and a transmission model (table 2).
All other markers tested in the present study yieldedZmax
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Table 3
Two-Point Zmax Values for Linkage Analysis with TS in a Charlevoix Pedigree ( ), for Chromosomes 11 and 13Np 127
MARKER
MAP
POSITION
(cM)
Zmax (v) FOR
Narrow Phenotype ( )Np 20 Intermediate Phenotype ( )Np 33 Broad Phenotype ( )Np 40
Model 1a Model 3a Model 2a Model 3 Model 2 Model 3
D11S1377 120.9 1.60 (.1) 2.40 (.1) 0 (.5) 1.30 (.15) .70 (.25) .90 (.15)
D11S933 124.1 1.01 (.2) 1.27 (.2) .13 (.4) .67 (.2) .43 (.3) 1.15 (.15)
D13S1325 45.6 .30 (.25) .10 (.3) 0 (.45) .10 (.1) 0 (.35) 1.30 (0)
D13S788 45.6 2.60 (0) 3.20 (0) .10 (.45) 1.80 (.05) 0 (.5) .70 (.1)
a Penetrance values characterizing the model are given in table 2.
values1.0. Three-point linkage analyses that combined
two adjacent markers with the disease locus were per-
formed on chromosomes 11 and 13, for the narrow phe-
notype definition under model 3. On chromosome 11,
the analysis involved markers D11S1377 and D11S933,
assuming a distance of 3.2 cM between them. A three-
point Zmax value of 3.24 was obtained that localized the
TS locus 10 cM centromeric to D11S1377. On chro-
mosome 13, the analysis involved markers D13S1325
and D13S788, assuming a v value of .0. The correspond-
ing three-point Zmax was only 0.0.
We assessed the potential impact that a misspecifica-
tion in marker-allele frequencies would have on our re-
sults, by reanalyzing chromosomes 11 and 13 on the
basis of two different sets of marker-allele frequencies,
fixing the model-phenotype combination to model 3
with the narrow phenotype definition; we used both a
set of published marker-allele frequencies (using the dif-
ferent sources of marker information provided above)
and a set obtained by assigning the same frequency to
all alleles. The three-point analysis involving markers
D11S1377 and D11S933 and these two new sets of
marker-allele frequencies led to three-point Zmax values
of 3.35 and 3.38, respectively. With marker D13S788,
the two sets yielded two-point Zmax values of 3.1 and
3.8, respectively, compared with the 3.2 originally ob-
tained by use of our population-based estimates. Hence,
globally, the impact that varying marker-allele frequen-
cies had on our results was to slightly increase the linkage
evidence obtained by use of our own population-based
estimates.
Figure 1 shows the family with haplotypes constructed
on the basis of markers D11S1377 and D11S933. Al-
though haplotype 5-4 was often found among affected
subjects, it was not seen systematically in all of them.
Therefore, we performed a sensitivity analysis to study
the impact that each individual branch of the family had
on our results. We found that, when the branch starting
with subjects 13 and 57 was ignored by giving an un-
known phenotype to the seven implied subjects (encom-
passed by the larger broken-line box in fig. 1), the three-
point Zmax on chromosome 11 rose to 4.53. When the
branch including subjects 45 and 46 and their two chil-
dren was ignored, the three-point Zmax rose to 3.92.
Moreover, when both branches were ignored, the three-
point Zmax reached 5.94. This sensitivity analysis re-
flected the absence of haplotype 5-4 in these two
branches. The impact of ignoring any other branch was
to decrease the LOD score on chromosome 11. The pres-
ence of haplotype 5-4 among unaffected subjects was
compatible with the mode of inheritance (model 3) that
assumed incomplete penetrance. The sensitivity analysis
performed on chromosome 13 showed that all branches
contributed to the two-point Zmax of 3.2 obtained at
D13S788, because omitting any one of them decreased
the LOD score.
The three-point Zmax of 3.24 obtained on chromo-
some 11 with markers D11S1377 and D11S933 reached
our predetermined threshold for significance—that is,
3.18. It is interesting to note that D11S933 is only 7 cM
from D11S912, a marker that, in the genome scan re-
ported by The Tourette Syndrome Association Interna-
tional Consortium for Genetics (1999), yielded a mul-
tipoint maximum-likelihood score of 1–2. Moreover,
D11S1377 is the marker that, in the Afrikaner popu-
lation studied by Simonic et al. (1998), showed the most
significant linkage disequilibriumwith TS. Therefore,we
concluded that, in this Charlevoix family, a gene for TS
may be located on chromosome 11 (11q23). Although
the evidence provided by the present study is statistically
significant, one must have a replication or an extension
study before reaching a final conclusion as to the exis-
tence of a TS gene on 11q23, as recommended for com-
plex disorders (Lander and Kruglyak 1995). To accom-
plish this, we are increasing the sample by studying
additional families.
With regard to chromosome 13, results remained am-
biguous, because the Zmax of 3.2 that initially was found
for marker D13S788 in the two-point analysis was not
supported by the multipoint analysis involving both
D13S788 and D13S1325. However, negative results in
multipoint analysis must be interpreted with caution,
because such an analysis is sensitive to power loss due
to misspecification of intermarker distances (Halpern
Reports 1013
and Whittemore 1999). In future work, we will attempt
to clarify the situation, by genotyping additional mark-
ers in the vicinity of D13S788.
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